Ventas (VTR) to Release Quarterly Earnings on Thursday

Ventas (NYSE:VTR) is expected to post its Q4 2025 results after the market closes on Thursday, February 5th. Analysts expect Ventas to post earnings of $0.89 per share and revenue of $1.5325 billion for the quarter. Parties can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Friday, February 6, 2026 at 10:00 AM ET.

Ventas Trading Up 0.4%

Shares of VTR opened at $77.70 on Wednesday. Ventas has a twelve month low of $58.72 and a twelve month high of $81.89. The company has a current ratio of 0.32, a quick ratio of 0.32 and a debt-to-equity ratio of 1.01. The firm has a market capitalization of $36.50 billion, a P/E ratio of 149.43, a PEG ratio of 1.93 and a beta of 0.77. The firm’s 50-day moving average is $78.14 and its two-hundred day moving average is $73.00.

Ventas Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, January 15th. Investors of record on Wednesday, December 31st were issued a $0.48 dividend. The ex-dividend date was Wednesday, December 31st. This represents a $1.92 dividend on an annualized basis and a dividend yield of 2.5%. Ventas’s dividend payout ratio is currently 369.23%.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the company. Weiss Ratings raised Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a report on Monday, December 29th. Citigroup lifted their price target on Ventas from $80.00 to $88.00 and gave the stock a “buy” rating in a research note on Tuesday, November 11th. Scotiabank boosted their price objective on shares of Ventas from $74.00 to $80.00 and gave the stock a “sector perform” rating in a research report on Thursday, November 13th. KeyCorp raised their target price on shares of Ventas from $70.00 to $85.00 and gave the company an “overweight” rating in a report on Thursday, December 4th. Finally, Wells Fargo & Company lifted their target price on shares of Ventas from $80.00 to $88.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 25th. Fourteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, Ventas currently has an average rating of “Moderate Buy” and an average price target of $81.63.

Insider Activity

In other Ventas news, CFO Robert F. Probst sold 33,591 shares of the stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $76.77, for a total transaction of $2,578,781.07. Following the transaction, the chief financial officer owned 168,364 shares of the company’s stock, valued at $12,925,304.28. This represents a 16.63% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Peter J. Bulgarelli sold 2,771 shares of the firm’s stock in a transaction on Tuesday, November 18th. The stock was sold at an average price of $80.01, for a total value of $221,707.71. Following the sale, the chief executive officer owned 108,717 shares in the company, valued at $8,698,447.17. This trade represents a 2.49% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 130,929 shares of company stock valued at $10,188,119 over the last 90 days. Insiders own 1.00% of the company’s stock.

Hedge Funds Weigh In On Ventas

Several large investors have recently added to or reduced their stakes in the business. Wiser Advisor Group LLC purchased a new stake in Ventas in the 3rd quarter valued at about $27,000. WFA of San Diego LLC acquired a new stake in shares of Ventas in the second quarter worth approximately $73,000. MUFG Securities EMEA plc purchased a new stake in Ventas in the second quarter valued at approximately $84,000. Geneos Wealth Management Inc. grew its holdings in Ventas by 39.4% in the second quarter. Geneos Wealth Management Inc. now owns 1,323 shares of the real estate investment trust’s stock valued at $84,000 after purchasing an additional 374 shares during the period. Finally, Brown Brothers Harriman & Co. increased its position in Ventas by 202.7% during the third quarter. Brown Brothers Harriman & Co. now owns 1,550 shares of the real estate investment trust’s stock worth $108,000 after purchasing an additional 1,038 shares during the last quarter. 94.18% of the stock is currently owned by hedge funds and other institutional investors.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.